Remove Genetics and mental health Remove Personality disorders Remove Reference
article thumbnail

The Moral World of Personality Disorder Assessment

Mad in America

W hen asked about her behavior during a psychiatric assessment for personality disorders, one patient’s response included this description: It was completely crazy. Professionals assess and diagnose the disorder situated in a patient’s mind so that interventions can be targeted to alleviate the disorder.

article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Health care professionals should monitor the child’s growth and development and provide necessary interventions to mitigate weight loss.” 3 References 1. June 30, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Depression: Biological or Psychological?

Mad in America

J ust about everyone believes that depressionthe #1 psychiatric diagnosisis explained in the same way as physical illnesses; that is, that depression, too, is of genetic/physiological origin. NIMH and psychiatrists have not always explained depression to be genetic (as “running in the family). Their efforts have failed.

article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

article thumbnail

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

Psychiatric Times

Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder. 2 With the potential benefits of developing lab-based diagnostic tools, there are unfortunately no definitive blood tests for bipolar disorder currently. References 1.

article thumbnail

Power, Privilege & Controlling the Narrative: Vested Interests in ‘Mental Health’

Mad in America

It was written by David Hansen, a crisis worker at a person-centred, survivor-led mental health crisis service. I have tasked myself with mapping out my understanding of how therapy and mental health relate to politics. Mental health is also political. Is therapy political? Is therapy political?

article thumbnail

Prodromal Symptoms of Schizophrenia: Understanding and Addressing Challenges

Psychiatric Times

Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. The DSM-5 task force concluded that there was not enough evidence to justify incorporating APS as an official mental disorder diagnosis in Section II.